June 12, 2019
- Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody-CD38.
- Realm Therapeutics plc - Leading Independent Proxy Advisory Firm ISS Recommends Voting for Proposed Acquisition by Essa Pharma.
- Eisai Inc. - Lemborexant Respiratory Safety Data Presented at SLEEP 2019.
- Eisai Inc. - Extensive Analyses of Phase 3 Data for Investigational Lemborexant Assess Efficacy and Safety Profile for the Potential Treatment of Insomnia in Adults.
- Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance.
- The healthcare of tomorrow Boehringer Ingelheim relies on digital transformation.
- Asarina Pharma - Premenstrual Dysphoric Disorder recognized in new WHO International Classification of Diseases ICD-11.
- Essentra plc - Divestment of Extrusion business.
- LHC Group is top performer in latest CMS Star quality and patient satisfaction scores.